Precision, Speed, and Convenience: How POCT is Reshaping Medical Diagnostic Scenarios
I. From “Hours” to “Minutes” – The POCT Efficiency Revolution
In the “golden hour” of emergency care, every minute counts. Traditional laboratory testing requires samplecollection, transportation, processing, and reporting—often taking several hours to deliver results. Point‑of‑Care Testing (POCT) dramatically shortens this cycle, truly enabling a “sample in, result out” bedside testing model.
POCT is not merely equipment miniaturization—it represents a profound scenario revolution:
*Emergency Room: Cardiac biomarker testing cut from 2 hours to 15 minutes, buying critical time for heart attack patients
*Infection Control: Rapid pathogen identification enables precise antibiotic use and reduces overuse
*Primary Healthcare: Empowers facilities without large lab infrastructure to deliver accurate testing, bridging medical resource gaps
II. Focus on Digestive Health – POCT Solutions for H. pylori Screening
China faces a significant Helicobacter pylori (Hp) infection burden, a major risk factor for gastric cancer.
| Key Data Point | Value |
| Hp Infection Rate in China | ~50% |
| Breath Test Turnaround Time | 250mins |
| Test Sensitivity | >95% |
| Patient Compliance with Gastroscopy | Low (invasive, discomfort) |
Traditional gastroscopy often deters patients due to its invasive nature. As a typical POCT application in gastroenterology, the urea breath test requires patients only to take a reagent capsule and blow into a collection device—yielding results in approximately 25–30 minutes. It is non‑invasive, pain‑free, and contamination‑free, making it especially suitable for large‑scale population screening and treatment monitoring.
III. Our Products – Engineered for Precision Diagnosis
As a professional R&D and manufacturing enterprise in the POCT field, we offer our independently developed core product lines:
*Fluorescence Immunoassay Analyzer Series
| Model | Technology Platform | Key Features | Primary Applications |
| Fluorescence immunochromatography | Easy operation, quantitative/qualitative dual modes | Infectious disease&chronic disease biomarker testing | |
| WIZ‑A203 | Fluorescence immunochromatography | High throughput, smart data processing | Multiplex testing, clinical batch screening |
*Gastric Urea Breath Test Instrument Series
| Model | Detection Principle | Key Advantages | Primary Applications |
Urea C14 ![]() |
¹⁴C isotope breath test | Low cost, ideal for mass screening | Community checkups, primary care screening |
| ¹³C isotope breath test | Non‑radioactive, broader patient eligibility | Pregnant women, children, premium health checkups |
IV. Looking Ahead
The future of POCT extends beyond diagnostics—it will become a critical link connecting ”rapid diagnosis, precision therapy, and health management.” We remain committed to advancing our products toward greater accuracy, portability, and intelligence, so that high‑quality diagnostic services can benefit even broader populations.
Post time: Jul-21-2026









